Cellular Health Testing Market hits at a CAGR of 10.0% by 2022

Posted by Kriti on July 16th, 2019

The global Cellular Health Testing Market is expected to reach USD 3.42 Billion by 2022 from USD 2.12 Billion in 2017, at a CAGR of 10.0% during the forecast period.

The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cellular Health Testing Market, along with revenue estimates & forecasts and market share analysis.

The increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are the major factors that are expected to drive the growth of the cellular health screening market.

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930

Cellular Health Testing Market

Cellular Health Testing Market segmentation:

  • Based on Type
  • Based on Sample Type
  • Based on Collection Site
  • Based on regions

The Major Players Opearting in the Cellular Health Testing Market:

Key players in the Cellular Health Testing Market include Genova Diagnostics (US), Telomere Diagnostics (US), Life Length (Spain), Quest Diagnostics (US), Repeat Diagnostics (Canada), SpectraCell Laboratories (US), Zimetry LLC (US), Cell Science Systems (US), Titanovo, Inc. (US), Segterra, Inc. (US), LabCorp Holdings (US), BioReference Laboratories (US), Immundiagnostik AG (Germany), DNA Labs (India), and Cleveland HeartLab, Inc. (US).

Telomere Diagnostics was the leading player in the global Cellular Health Testing Market.

Telomere majorly focuses on developing new products that offer innovative solutions to help people test their cellular health and take preventive and therapeutic measures as required. For instance, in 2016, the company launched the TeloYears genetic test, which helps track the cellular age of an individual based on the telomere length.

Geographical Detailed Analysis for Cellular Health Testing Market:

North America is the largest regional segment in the Cellular Health Testing Market followed by Europe, Asia, and the Rest of the World (Row).

The high growth of the North American market is attributed to the factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region.

Read More in Detailed (Cellular Health Testing):



Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Like it? Share it!


About the Author

Joined: July 3rd, 2019
Articles Posted: 390

More by this author